Federal award (BPA CALL, fiscal year 2024)
Recipient: CERILLIANT CORPORATION
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2025-03-04 to 2025-09-30
Current total value of award: $22803.21
Description: DRUG SCREENING AND ATION TESTING FOR SUSPECTED DRUG USE IN SERVICE MEMBER INVESTIGATIVE AND/OR POST-MORTEM URINE, BLOOD AND TISSUE SAMPLES.